A cancer immunotherapy modality based on dendritic cell reprogrammingin vivo

Ascic E, Åkerström F, Sreekumar Nair M, Rosa A, Kurochkin I, Zimmermannova O, Catena X, Rotankova N, Veser C, Rudnik M, Ballocci T, Schärer T, Huang X, de Rosa Torres M, Renaud E, Velasco Santiago M, Met Ö, Askmyr D, Lindstedt M, Greiff L, Ligeon LA, Agarkova I, Svane IM, Pires CF, Rosa FF, Pereira CF

- - (-) - [2024-07-11; online 2024-07-11]

Clinical Genomics Lund [Service]

DOI 10.1101/2024.07.08.602356

Crossref 10.1101/2024.07.08.602356


Publications 9.5.1